US99823A
(en)
|
|
1870-02-15 |
|
Improved indigo soap |
US5885613A
(en)
|
1994-09-30 |
1999-03-23 |
The University Of British Columbia |
Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
|
US5801030A
(en)
|
1995-09-01 |
1998-09-01 |
Genvec, Inc. |
Methods and vectors for site-specific recombination
|
AU733310C
(en)
|
1997-05-14 |
2001-11-29 |
University Of British Columbia, The |
High efficiency encapsulation of charged therapeutic agents in lipid vesicles
|
US6693086B1
(en)
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
WO2002087541A1
(en)
|
2001-04-30 |
2002-11-07 |
Protiva Biotherapeutics Inc. |
Lipid-based formulations for gene transfer
|
EP1664316B1
(en)
|
2003-09-15 |
2012-08-29 |
Protiva Biotherapeutics Inc. |
Polyethyleneglycol-modified lipid compounds and uses thereof
|
JP4380411B2
(ja)
|
2004-04-30 |
2009-12-09 |
澁谷工業株式会社 |
滅菌方法
|
EP2992902A1
(en)
|
2004-12-27 |
2016-03-09 |
Silence Therapeutics GmbH |
Lipid complexes coated with peg and their uses
|
US7404969B2
(en)
|
2005-02-14 |
2008-07-29 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
US7451428B2
(en)
|
2005-02-24 |
2008-11-11 |
Texas Instruments Incorporated |
Merging sub-resolution assist features of a photolithographic mask through the use of a merge bar
|
GB0600948D0
(en)
*
|
2006-01-18 |
2006-02-22 |
Univ Dundee |
Prevention/Treatment Of Ichthyosis Vulgaris, Atopy And Other Disorders
|
JP2009534690A
(ja)
|
2006-07-10 |
2009-09-24 |
メムシック,インコーポレイテッド |
磁場センサーを用いて偏揺れを感知するためのシステム、および、前記システムを用いた携帯用の電子装置
|
WO2009086558A1
(en)
|
2008-01-02 |
2009-07-09 |
Tekmira Pharmaceuticals Corporation |
Improved compositions and methods for the delivery of nucleic acids
|
PL2279254T3
(pl)
|
2008-04-15 |
2017-11-30 |
Protiva Biotherapeutics Inc. |
Nowe preparaty lipidowe do dostarczania kwasów nukleinowych
|
WO2009132131A1
(en)
|
2008-04-22 |
2009-10-29 |
Alnylam Pharmaceuticals, Inc. |
Amino lipid based improved lipid formulation
|
EP2350043B9
(en)
|
2008-10-09 |
2014-08-20 |
TEKMIRA Pharmaceuticals Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
ES2656516T3
(es)
|
2008-10-20 |
2018-02-27 |
Alnylam Pharmaceuticals, Inc. |
Composiciones y métodos para inhibir la expresión de transtiretina
|
MX353900B
(es)
|
2008-11-07 |
2018-02-01 |
Massachusetts Inst Technology |
Lipidoides de aminoalcohol y usos de los mismos.
|
KR102264822B1
(ko)
|
2008-11-10 |
2021-06-14 |
알닐람 파마슈티칼스 인코포레이티드 |
치료제 운반용 신규 지질 및 조성물
|
WO2010054384A1
(en)
|
2008-11-10 |
2010-05-14 |
Alnylam Pharmaceuticals, Inc. |
Lipids and compositions for the delivery of therapeutics
|
EA028860B1
(ru)
|
2009-06-10 |
2018-01-31 |
Арбутус Биофарма Корпорэйшн |
Улучшенная липидная композиция
|
JP5766188B2
(ja)
|
2009-07-01 |
2015-08-19 |
プロチバ バイオセラピューティクス インコーポレイティッド |
固形腫瘍に治療剤を送達するための脂質製剤
|
WO2011000106A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Improved cationic lipids and methods for the delivery of therapeutic agents
|
ES2579936T3
(es)
|
2009-08-20 |
2016-08-17 |
Sirna Therapeutics, Inc. |
Nuevos lípidos catiónicos con diversos grupos de cabeza para el suministro oligonucleotídico
|
EP2506879A4
(en)
|
2009-12-01 |
2014-03-19 |
Protiva Biotherapeutics Inc |
PREPARATIONS OF SNALP CONTAINING ANTIOXIDANTS
|
EP3296398A1
(en)
|
2009-12-07 |
2018-03-21 |
Arbutus Biopharma Corporation |
Compositions for nucleic acid delivery
|
US20130116419A1
(en)
|
2010-01-22 |
2013-05-09 |
Daniel Zewge |
Post-synthetic chemical modification of rna at the 2'-position of the ribose ring via "click" chemistry
|
WO2011097480A1
(en)
|
2010-02-05 |
2011-08-11 |
University Of Louisville Research Foundation, Inc. |
Exosomal compositions and methods for the treatment of disease
|
JP4782232B1
(ja)
|
2010-04-09 |
2011-09-28 |
シャープ株式会社 |
光源モジュール、及びそれを備えた電子機器
|
EP2569276B1
(en)
|
2010-05-12 |
2021-02-24 |
Arbutus Biopharma Corporation |
Novel cationic lipids and methods of use thereof
|
WO2011141704A1
(en)
|
2010-05-12 |
2011-11-17 |
Protiva Biotherapeutics, Inc |
Novel cyclic cationic lipids and methods of use
|
IL300109A
(en)
|
2010-06-03 |
2023-03-01 |
Alnylam Pharmaceuticals Inc |
Biodegradable lipids for the transfer of active substances
|
EP2575767B1
(en)
|
2010-06-04 |
2017-01-04 |
Sirna Therapeutics, Inc. |
Novel low molecular weight cationic lipids for oligonucleotide delivery
|
US9006417B2
(en)
|
2010-06-30 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
US9676810B2
(en)
*
|
2010-07-08 |
2017-06-13 |
The Brigham And Women's Hospital, Inc. |
Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules
|
WO2012016184A2
(en)
|
2010-07-30 |
2012-02-02 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
EP3542789A3
(en)
|
2010-08-31 |
2020-01-01 |
GlaxoSmithKline Biologicals SA |
Lipids suitable for liposomal delivery of protein-coding rna
|
BR112013004585B1
(pt)
|
2010-09-20 |
2021-09-08 |
Merck Sharp & Dohme Corp |
Lipídeo catiônico, composição de lnp, e, uso de um lipídeo catiônico
|
CA2811430A1
(en)
|
2010-09-30 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Low molecular weight cationic lipids for oligonucleotide delivery
|
CN103153347A
(zh)
|
2010-10-21 |
2013-06-12 |
默沙东公司 |
用于寡核苷酸递送的新型低分子量阳离子脂质
|
US9617461B2
(en)
|
2010-12-06 |
2017-04-11 |
Schlumberger Technology Corporation |
Compositions and methods for well completions
|
AU2012207606B2
(en)
|
2011-01-11 |
2017-02-23 |
Alnylam Pharmaceuticals, Inc. |
Pegylated lipids and their use for drug delivery
|
WO2012162210A1
(en)
|
2011-05-26 |
2012-11-29 |
Merck Sharp & Dohme Corp. |
Ring constrained cationic lipids for oligonucleotide delivery
|
WO2013016058A1
(en)
|
2011-07-22 |
2013-01-31 |
Merck Sharp & Dohme Corp. |
Novel bis-nitrogen containing cationic lipids for oligonucleotide delivery
|
EP3456317A1
(en)
|
2011-09-27 |
2019-03-20 |
Alnylam Pharmaceuticals, Inc. |
Di-aliphatic substituted pegylated lipids
|
PE20150041A1
(es)
|
2011-10-27 |
2015-01-28 |
Massachusetts Inst Technology |
Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco
|
US20140308212A1
(en)
|
2011-11-07 |
2014-10-16 |
University Of Louisville Research Foundation, Inc. |
Edible plant-derived microvesicle compositions for diagnosis and treatment of disease
|
WO2013073480A1
(ja)
|
2011-11-18 |
2013-05-23 |
日油株式会社 |
細胞内動態を改善したカチオン性脂質
|
WO2013086373A1
(en)
|
2011-12-07 |
2013-06-13 |
Alnylam Pharmaceuticals, Inc. |
Lipids for the delivery of active agents
|
EP3988537A1
(en)
|
2011-12-07 |
2022-04-27 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
CA3170051A1
(en)
|
2011-12-07 |
2013-06-13 |
Alnylam Pharmaceuticals, Inc. |
Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents
|
JP6182457B2
(ja)
|
2011-12-12 |
2017-08-16 |
協和発酵キリン株式会社 |
カチオン性脂質を含有するドラックデリバリーシステムのための脂質ナノ粒子
|
WO2013116126A1
(en)
|
2012-02-01 |
2013-08-08 |
Merck Sharp & Dohme Corp. |
Novel low molecular weight, biodegradable cationic lipids for oligonucleotide delivery
|
WO2013126803A1
(en)
|
2012-02-24 |
2013-08-29 |
Protiva Biotherapeutics Inc. |
Trialkyl cationic lipids and methods of use thereof
|
AU2013240051B2
(en)
|
2012-03-27 |
2017-11-30 |
Sirna Therapeutics, Inc. |
Diether based biodegradable cationic lipids for siRNA delivery
|
ES2887254T3
(es)
|
2013-03-08 |
2021-12-22 |
Novartis Ag |
Lípidos y composiciones lipídicas para el suministro de agentes activos
|
WO2015011633A1
(en)
|
2013-07-23 |
2015-01-29 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for delivering messenger rna
|
MX2016005238A
(es)
|
2013-10-22 |
2016-08-12 |
Shire Human Genetic Therapies |
Formulaciones de lipidos para la administracion de acido ribonucleico mensajero.
|
JP6486955B2
(ja)
|
2013-11-18 |
2019-03-20 |
アークトゥルス セラピューティクス, インコーポレイテッド |
Rna送達のためのイオン化可能なカチオン性脂質
|
US9365610B2
(en)
|
2013-11-18 |
2016-06-14 |
Arcturus Therapeutics, Inc. |
Asymmetric ionizable cationic lipid for RNA delivery
|
EP3071515A2
(en)
|
2013-11-18 |
2016-09-28 |
Rubius Therapeutics, Inc. |
Synthetic membrane-receiver complexes
|
ES2774968T3
(es)
|
2013-12-19 |
2020-07-23 |
Novartis Ag |
Lípidos y composiciones lipídicas para la administración de agentes activos
|
WO2015095346A1
(en)
|
2013-12-19 |
2015-06-25 |
Novartis Ag |
Lipids and lipid compositions for the delivery of active agents
|
AU2015241422B2
(en)
|
2014-04-01 |
2020-12-03 |
Rubius Therapeutics, Inc. |
Methods and compositions for immunomodulation
|
CN106795096B
(zh)
|
2014-06-25 |
2020-05-29 |
爱康泰生治疗公司 |
用于递送核酸的新型脂质和脂质纳米颗粒制剂
|
WO2016115632A1
(en)
*
|
2015-01-21 |
2016-07-28 |
Exerkine Corporation |
Method for treating mitochondrial disease
|
US20180135012A1
(en)
|
2015-05-13 |
2018-05-17 |
Rubius Therapeutics, Inc. |
Membrane-receiver complex therapeutics
|
JP6800410B2
(ja)
|
2015-06-19 |
2020-12-16 |
マサチューセッツ インスティテュート オブ テクノロジー |
アルケニル置換2,5−ピペラジンジオン、および、対象または細胞に剤を送達するための組成物におけるそれらの使用
|
DK3313829T3
(da)
|
2015-06-29 |
2024-06-17 |
Acuitas Therapeutics Inc |
Lipider og lipide nanopartikelformuleringer til levering af nukleinsyrer
|
US20180362974A1
(en)
|
2015-07-02 |
2018-12-20 |
University Of Louisville Research Foundation, Inc. |
EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DELIVERY OF miRNA AND METHODS FOR TREATMENT OF CANCER
|
LT3350157T
(lt)
|
2015-09-17 |
2022-02-25 |
Modernatx, Inc. |
Junginiai ir kompozicijos terapinei medžiagai teikti intraceliuliniu būdu
|
CA3201644A1
(en)
|
2015-10-28 |
2017-05-04 |
Acuitas Therapeutics, Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
AU2016366978B2
(en)
|
2015-12-10 |
2022-07-28 |
Modernatx, Inc. |
Compositions and methods for delivery of therapeutic agents
|
US20190022247A1
(en)
|
2015-12-30 |
2019-01-24 |
Acuitas Therapeutics, Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
KR20180095098A
(ko)
|
2016-01-11 |
2018-08-24 |
루비우스 테라퓨틱스, 아이엔씨. |
암 적응증에 대한 다중양식 치료 세포 시스템과 관련된 조성물 및 방법
|
WO2017173054A1
(en)
|
2016-03-30 |
2017-10-05 |
Intellia Therapeutics, Inc. |
Lipid nanoparticle formulations for crispr/cas components
|
JP7080826B2
(ja)
|
2016-05-16 |
2022-06-06 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
カチオン性スルホンアミドアミノ脂質および両親媒性両性イオンアミノ脂質
|
US20200315967A1
(en)
|
2016-06-24 |
2020-10-08 |
Modernatx, Inc. |
Lipid nanoparticles
|
KR20190026819A
(ko)
|
2016-07-07 |
2019-03-13 |
루비우스 테라퓨틱스, 아이엔씨. |
외인성 rna를 발현하는 치료용 세포 시스템과 관련된 조성물 및 방법
|
EP3532103A1
(en)
|
2016-10-26 |
2019-09-04 |
Acuitas Therapeutics, Inc. |
Lipid nanoparticle formulations
|
KR20190091497A
(ko)
|
2016-12-02 |
2019-08-06 |
루비우스 테라퓨틱스, 아이엔씨. |
고형 종양으로의 침투를 위한 세포 시스템과 관련된 조성물 및 방법
|
MX2019009839A
(es)
|
2017-02-17 |
2019-10-22 |
Rubius Therapeutics Inc |
Celulas eritroides funcionalizadas.
|
MX2019013312A
(es)
|
2017-05-08 |
2020-08-17 |
Flagship Pioneering Innovations V Inc |
Composiciones para facilitar la fusion de membranas y usos de estas.
|
EP3679148A4
(en)
|
2017-09-08 |
2021-06-09 |
Generation Bio Co. |
LIPID NANOPARTICLE FORMULATIONS OF NON-VIRAL CAPSIDE-FREE DNA VECTORS
|
TWI833708B
(zh)
|
2017-09-29 |
2024-03-01 |
美商英特利亞醫療公司 |
調配物
|
BR112020005323A2
(pt)
|
2017-09-29 |
2020-09-24 |
Intellia Therapeutics, Inc. |
polinucleotídeos, composições e métodos para edição de genoma
|
WO2019217941A1
(en)
|
2018-05-11 |
2019-11-14 |
Beam Therapeutics Inc. |
Methods of suppressing pathogenic mutations using programmable base editor systems
|
US20210378980A1
(en)
|
2018-09-20 |
2021-12-09 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
BR112021005788A2
(pt)
*
|
2018-09-26 |
2021-10-26 |
Case Western Reserve University |
Métodos e composições para aumentar a expressão de proteínas e/ou tratar um distúrbio de haploinsuficiência
|
EP3867225A1
(en)
|
2018-10-18 |
2021-08-25 |
Acuitas Therapeutics, Inc. |
Lipids for lipid nanoparticle delivery of active agents
|
AU2019384557A1
(en)
|
2018-11-21 |
2021-06-10 |
Translate Bio, Inc. |
Treatment of cystic fibrosis by delivery of nebulized mRNA encoding CFTR
|
US11166996B2
(en)
|
2018-12-12 |
2021-11-09 |
Flagship Pioneering Innovations V, Inc. |
Anellovirus compositions and methods of use
|
WO2020150608A1
(en)
*
|
2019-01-18 |
2020-07-23 |
Flagship Pioneering, Inc. |
Trem compositions and uses thereof
|
CA3137956A1
(en)
|
2019-04-25 |
2020-10-29 |
Intellia Therapeutics, Inc. |
Ionizable amine lipids and lipid nanoparticles
|
WO2020243560A1
(en)
*
|
2019-05-31 |
2020-12-03 |
Flagship Pioneering, Inc. |
Uses of trem compositions to modulate trna pools
|
CA3160097A1
(en)
*
|
2019-11-04 |
2021-05-14 |
Flagship Pioneering, Inc. |
Trem compositions for con-rare codons and related uses
|